BLCO
Bausch + Lomb Corp.

522
Mkt Cap
$6.12B
Volume
440,470.00
52W High
$18.99
52W Low
$10.45
PE Ratio
-19.67
BLCO Fundamentals
Price
$16.99
Prev Close
$17.27
Open
$17.33
50D MA
$15.62
Beta
1.09
Avg. Volume
485,997.16
EPS (Annual)
-$0.9011
P/B
0.94
Rev/Employee
$354,888.89
Loading...
Loading...
News
all
press releases
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (Bausch + Lomb or the company), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated...
Business Wire·9h ago
News Placeholder
More News
News Placeholder
Bausch + Lomb Corporation $BLCO Stock Holdings Raised by Goldentree Asset Management LP
Goldentree Asset Management LP raised its holdings in shares of Bausch + Lomb Corporation (NYSE:BLCO - Free Report) by 14.9% during the 2nd quarter, according to the company in its most recent filing...
MarketBeat·4d ago
News Placeholder
Arrowstreet Capital Limited Partnership Decreases Stock Holdings in Bausch + Lomb Corporation $BLCO
Arrowstreet Capital Limited Partnership trimmed its holdings in Bausch + Lomb Corporation (NYSE:BLCO - Free Report) by 26.9% in the second quarter, according to its most recent disclosure with the...
MarketBeat·4d ago
News Placeholder
Oaktree Capital Management LP Makes New Investment in Bausch + Lomb Corporation $BLCO
Oaktree Capital Management LP purchased a new position in shares of Bausch + Lomb Corporation (NYSE:BLCO - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing...
MarketBeat·8d ago
News Placeholder
Stock market news: Dow, S&P, Nasdaq slip; US big pharma deal with UK, and Bitcoin falters
December did not start well for the market, with all the major indices in the red. Will the theories urging caution against expecting a Santa Claus rally hold? Well, this is just Day 1, and for some...
TheStreet.com·11d ago
News Placeholder
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Recommendation of "Hold" by Analysts
Bausch + Lomb Corporation (NYSE:BLCO - Get Free Report) has received an average recommendation of "Hold" from the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports...
MarketBeat·17d ago
News Placeholder
Bausch + Lomb to Participate in Citi Global Healthcare Conference
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and...
Business Wire·24d ago
News Placeholder
Bausch + Lomb (NYSE:BLCO) Given New $19.00 Price Target at Royal Bank Of Canada
Royal Bank Of Canada raised their price objective on Bausch + Lomb from $17.00 to $19.00 and gave the company an "outperform" rating in a research note on Friday...
MarketBeat·28d ago
News Placeholder
Wells Fargo & Company Increases Bausch + Lomb (NYSE:BLCO) Price Target to $17.00
Wells Fargo & Company raised their price target on Bausch + Lomb from $16.00 to $17.00 and gave the company an "equal weight" rating in a report on Friday...
MarketBeat·28d ago
News Placeholder
NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership
NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership NYSE Content Advisory: Pre-Market Update + TKO and Polymarket Announce Partnership PR Newswire NEW YORK, Nov. 13...
PR Newswire·30d ago

Latest BLCO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.